Kobo Biotech Ltd

Surging from a 52-week low of Rs 1.99 to a fresh high of Rs 6.84 on 18 Jun 2026, Kobo Biotech Ltd has delivered an extraordinary 170.36% return over the past year, vastly outperforming the Sensex’s decline of 5.21%. This remarkable rally is underpinned by a strong alignment of technical indicators and sustained price momentum across multiple timeframes.

Surging past its previous peaks, Kobo Biotech Ltd reached a fresh 52-week high of Rs 6.71 today, marking a remarkable 148.52% gain over the past 21 trading days. This rally has propelled the stock well above all key moving averages, underscoring a powerful momentum shift in the commodity chemicals sector.

Surging past its previous peaks, Kobo Biotech Ltd reached a fresh 52-week high of Rs 6.58 on 16 Jun 2026, marking a remarkable rally of over 230% from its low of Rs 1.99 in the past year. This milestone comes amid a sustained uptrend supported by a confluence of bullish technical indicators and strong price momentum.

Surging past its previous peaks, Kobo Biotech Ltd reached a fresh 52-week high of Rs 6.46 on 15 Jun 2026, marking a remarkable rally of over 150% in the last 20 trading sessions. This momentum has been fuelled by a confluence of bullish technical indicators and sustained price strength, setting the stock apart in the commodity chemicals sector.

Surging past its previous peak, Kobo Biotech Ltd reached a new 52-week high of Rs 6.34 on 12 Jun 2026, marking a remarkable rally of 148.63% over the past year. This milestone comes amid a sustained 19-day consecutive gain, underscoring the stock's strong price momentum and technical alignment despite a broader market environment that remains cautious.

Surging past its previous peaks, Kobo Biotech Ltd touched a new 52-week high of Rs 6.04 on 11 Jun 2026, marking a remarkable 134.11% gain over the past 18 trading days. This rally stands in stark contrast to the broader market’s subdued performance, with the Sensex down 0.55% on the day and languishing near its 52-week low.

Surging past its previous peak, Kobo Biotech Ltd reached a fresh 52-week high of Rs 5.76 on 10 Jun 2026, marking a remarkable 123.26% gain over the past 17 trading days. This rally stands in stark contrast to the broader market, with the Sensex up just 0.52% today and still 3.71% above its 52-week low.

Surging past its previous peak, Kobo Biotech Ltd has reached a fresh 52-week high of Rs 5.49 on 09 Jun 2026, marking a remarkable 112.79% gain over the past 16 trading sessions. This rally stands out amid a broader market environment where the Sensex is struggling near its 52-week low, underscoring the stock's exceptional momentum.

With a sustained rally that has doubled its value over the past 15 trading sessions, Kobo Biotech Ltd surged to a fresh 52-week high of Rs 5.23 on 8 Jun 2026, outpacing its commodity chemicals sector peers and defying the broader market's subdued tone.

With a remarkable 84.5% gain over the past 13 trading days, Kobo Biotech Ltd surged to a fresh 52-week high of Rs 4.76 on 4 Jun 2026, defying the broader market's subdued tone and showcasing a powerful technical momentum that has captivated attention in the commodity chemicals sector.

Surging past its previous peaks, Kobo Biotech Ltd touched a new 52-week high of Rs 4.54 on 3 Jun 2026, marking a remarkable rally of over 75% in just 12 consecutive trading days. This momentum stands out sharply against the broader market’s decline, underscoring the stock’s technical resilience amid a challenging environment.

With a sustained 11-day winning streak culminating in a 4.84% gain today, Kobo Biotech Ltd has surged to a fresh 52-week high of Rs 4.33, marking a remarkable 67.83% return over this period and outperforming its sector by 5.2%.

Surging past its previous peak, Kobo Biotech Ltd reached a fresh 52-week high of Rs 4.13 on 1 Jun 2026, marking a remarkable rally of over 107% from its 52-week low of Rs 1.99. This milestone caps a sustained momentum run, with the stock gaining for ten consecutive sessions and outperforming its sector by 4.03% on the day.

Surging past its previous peaks, Kobo Biotech Ltd reached a fresh 52-week high of Rs 3.94 on 29 May 2026, propelled by a sustained nine-day rally that has delivered a remarkable 52.71% return over this period. This momentum outpaces the broader sector by 4.39% today, underscoring the stock’s robust technical positioning amid a mixed market backdrop.

With a sustained rally over the past eight sessions delivering a 45.74% gain, Kobo Biotech Ltd surged to a fresh 52-week high of Rs 3.76 on 27 May 2026, outpacing its commodity chemicals sector peers and the broader market.

With a sustained rally that has propelled Kobo Biotech Ltd to a fresh 52-week high of Rs 3.76 on 27 May 2026, the stock has demonstrated remarkable momentum, outpacing its sector and the broader market despite a subdued Sensex.

Surging past its previous peak, Kobo Biotech Ltd reached a fresh 52-week high of Rs 3.59 on 26 May 2026, marking a significant milestone in its recent price momentum. This breakout comes after a sustained seven-day rally that has delivered a remarkable 39.15% return, outpacing its commodity chemicals sector peers and the broader market.

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026. This change is primarily driven by a shift in technical indicators, despite persistent fundamental challenges and weak financial trends. The company’s stock price has shown modest recovery, but long-term performance and valuation concerns remain significant.

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026. This decisive change reflects deteriorating fundamentals, poor valuation metrics, a negative financial trend, and weak technical signals, signalling heightened risk for investors amid ongoing operational challenges and market underperformance.